GNOM Fail-to-Deliver

Global X - Genomics & Biotechnology ETF (GNOM) operates in the Financial Services sector, specifically the Asset Management - Global industry, with a market capitalization near $51.9M, listed on NASDAQ, carrying a beta of 1.57 to the broader market. The Global X Genomics & Biotechnology ETF (GNOM) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index. public since 2019-04-10.

Fail-to-deliver (FTD) data from the SEC tracks settlement failures where shares were not delivered within the standard settlement period. Persistent FTDs may indicate naked short selling or settlement issues and are monitored by regulators.

Latest Date
2026-04-28
Latest FTD Quantity
317
Latest Price
$45.55
30-Day Avg FTD
365
30-Day Total FTD
11.0K

Showing 30 days of SEC fail-to-deliver data for Global X - Genomics & Biotechnology ETF.

Learn how fails-to-deliver is reported and how to read the data →

Frequently asked GNOM fail to deliver questions

What is the latest GNOM fail-to-deliver count?
As of Apr 28, 2026, Global X - Genomics & Biotechnology ETF (GNOM) fail-to-deliver quantity is 317 shares, with a 30-day average of 365 shares. The SEC publishes FTD data twice monthly: first-half data at month-end, second-half around the 15th of the following month.
What is the FTD aggregate net balance?
FTD figures represent the aggregate net balance in NSCC's Continuous Net Settlement (CNS) system, not the gross failed-share count. The published numbers run 2-6 weeks stale relative to the underlying settlement date.
How do GNOM FTDs affect options pricing?
Persistent FTDs flag hard-to-borrow conditions that distort put-call parity: in HTB names, synthetic long stock (long call + short put at the same strike) trades below the frictionless-parity price by approximately the borrow rebate. The discount equals the lending revenue forgone by holding the synthetic instead of actual shares. Reg SHO threshold-list inclusion follows from sustained FTD persistence.